Journals / Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi / 2023 / Cilt: 18 Sayı: 3

Overview of Sarcopenia and Associated Factors

Sarkopeni’ye Genel Bakış ve İlişkili Faktörler

Pages
99–104
Publication Date
2023-11-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Physical activity alone or in combination with protein supplementation has been shown to be effective in preventing disability and fragility in older people by increasing muscle mass and strength

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sarcopenia is a progressive and generalized skeletal muscle disorder involving accelerated loss of muscle mass and function.
📊
Key Findings & Data:The diagnosis of sarcopenia is based on muscle mass measurements and functional tests that assess muscle strength or physical performance.
💡
Conclusion & Impact:Physical activity alone or in combination with protein supplementation has been shown to be effective in preventing disability and fragility in older people by increasing muscle mass and strength
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:sarkopeni · kırılganlık · geriatri

Abstract

Sarcopenia is a progressive and generalized skeletal muscle disorder involving accelerated loss of muscle mass and function. Physical activity and nutrition are the main ways to prevent sarcopenia. The diagnosis of sarcopenia is based on muscle mass measurements and functional tests that assess muscle strength or physical performance. The pathogenesis of sarcopenia is complex and multifactorial. In the absence of pharmacological drugs in the treatment of the disease in sarcopenic patients, non-pharmacological methods appear as the only option. Pharmacological treatment recommendations include vitamin D, testosterone, estrogens, protein and amino acids, growth hormone, fatty acids, vitamins and minerals. New researches continues in this area. Physical activity alone or in combination with protein supplementation has been shown to be effective in preventing disability and fragility in older people by increasing muscle mass and strength

Özet

Sarkopeni akselere kas kütle ve fonksiyon kaybını içeren progresif ve generalize kas iskelet bozukluğudur. Fiziksel aktivite ve beslenme sarkopeni önlenmesinde ana yollardır. Sarkopeni tanısı, kas kütle ölçümlerine ve kas gücünü veya fiziksel performansı değerlendiren fonksiyonel testlere dayanır. Sarkopeni patogenezi kompleks ve multifaktöryeldir. Sarkopenik hastalarda hastalığın tedavisinde farmakolojik ilaçların yokluğunda non-farmakolojik önlemler tek seçenek olarak karşımıza çıkmaktadır. Farmakolojik tedavi önerilerinde, vitamin D, testosteron, östrojenler, protein ve aminoasitler, büyüme hormonu, yağ asitleri, vitamin ve mineralleri içermektedir. Bu alanda yeni araştırmalar devam etmektedir. Fiziksel aktivitenin tek başına veya protein suplementasyonuyla birlikte ileri yaş kişilerde engellilik ve kırılganlığı önlemede kas kütlesi ve kuvvetini artırma yoluyla efektif olduğu gösterilmiştir.

🔖

Cite This Article

KOCA, T. T., YILDIZ, B. T. (2023). Overview of Sarcopenia and Associated Factors. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi, Cilt: 18 Sayı: 3, 99–104. https://ajindex.com/articles/1019229

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Dhillon RJ, Hasni S. Pathogenesis and Management of Sarcopenia. Clin Geriatr Med. 2017;33(1):17-26. doi: 10.1016/j.cger.2016.08.002. PMID: 27886695; PMCID: PMC5127276. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636-2646. doi: 10.1016/S0140-6736(19)31138-9. Epub 2019 Jun 3. Erratum in: Lancet. 2019 Jun 29;393(10191):2590. PMID: 31171417. Papadopoulou SK. Sarcopenia: A Contemporary Health Problem among Older Adult Populations. Nutrients. 2020;12(5):1293. doi: 10.3390/nu12051293. PMID: 32370051; PMCID: PMC7282252. Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, et al. A Time for Action. An SCWD Position Paper. J Cachexia Sarcopenia Muscle. 2019;10(5):956-961. doi: 10.1002/jcsm.12483. Epub 2019 Sep 15. PMID: 31523937; PMCID: PMC6818450. An HJ, Tizaoui K, Terrazzino S, Cargnin S, Lee KH, Nam SW, et al. Sarcopenia in Autoimmune and Rheumatic Diseases: A Comprehensive Review. Int J Mol Sci. 2020;21(16):5678. doi: 10.3390/ijms21165678. PMID: 32784808; PMCID: PMC7461030. Woo J. Sarcopenia. Clin Geriatr Med. 2017;33(3):305-314. doi: 10.1016/j.cger.2017.02.003. Epub 2017 May 13. PMID: 28689564. Dodds RM, Roberts HC, Cooper C, Sayer AA. The Epidemiology of Sarcopenia. J Clin Densitom. 2015;18(4):461-6. doi: 10.1016/j.jocd.2015.04.012. Epub 2015 Jun 12. PMID: 26073423; PMCID: PMC4629409. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169. Erratum in: Age Ageing. 2019;48(4):601. PMID: 30312372; PMCID: PMC6322506. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosisReport of the European Working Group on Sarcopenia in Older People A. Age Ageing 2010;39:412–423.
  2. Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging. 2018;22(10):1148-1161. doi: 10.1007/s12603-018-1139-9. PMID: 30498820. Walston JD. Sarcopenia in older adults. Curr Opin Rheumatol. 2012 Nov;24(6):623-7. doi: 10.1097/BOR.0b013e328358d59b. PMID: 22955023; PMCID: PMC4066461. Pascual-Fernández J, Fernández-Montero A, Córdova-Martínez A, Pastor D, Martínez-Rodríguez A